StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioLargo's revenue for the twelve months ending Jun 30, 2026 was $4.08M, down 70.9% year over year. For fiscal 2025 it was $7.77M, down 56.3% from the year before. Over ten years it grew 50.8% a year on average. The highest annual figure on record is $17.78M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.77M-56.3%
FY2024Dec 31, 2024$17.78M+45.4%
FY2023Dec 31, 2023$12.23M+107.9%
FY2022Dec 31, 2022$5.88M+132.5%
FY2021Dec 31, 2021$2.53M+4.1%
FY2020Dec 31, 2020$2.43M+30.7%
FY2019Dec 31, 2019$1.86M+36.4%
FY2018Dec 31, 2018$1.36M+164.3%
FY2017Dec 31, 2017$516.00K+83.6%
FY2016Dec 31, 2016$281.11K+120.3%
FY2015Dec 31, 2015$127.58K+14.4%
FY2014Dec 31, 2014$111.55K-33.6%
FY2013Dec 31, 2013$167.95K+156.2%
FY2012Dec 31, 2012$65.54K-58.0%
FY2011Dec 31, 2011$156.19K-0.4%
FY2010Dec 31, 2010$156.76K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.25M-55.1%
Q1 FY2026Mar 31, 2026$1.12M-65.9%
Q4 FY2025Dec 31, 2025$617.00K-83.1%
Q3 FY2025Sep 30, 2025$1.10M-74.6%
Q2 FY2025Jun 30, 2025$2.78M-44.6%
Q1 FY2025Mar 31, 2025$3.27M-31.3%
Q4 FY2024Dec 31, 2024$3.66M-16.3%
Q3 FY2024Sep 30, 2024$4.35M+62.8%
Q2 FY2024Jun 30, 2024$5.01M+246.7%
Q1 FY2024Mar 31, 2024$4.76M+27.2%
Q4 FY2023Dec 31, 2023$4.37M+108.3%
Q3 FY2023Sep 30, 2023$2.67M+78.1%
Q2 FY2023Jun 30, 2023$1.45M+9.3%
Q1 FY2023Mar 31, 2023$3.74M+287.8%
Q4 FY2022Dec 31, 2022$2.10M+166.2%
Q3 FY2022Sep 30, 2022$1.50M+110.7%
Q2 FY2022Jun 30, 2022$1.32M+185.1%
Q1 FY2022Mar 31, 2022$965.00K+69.0%
Q4 FY2021Dec 31, 2021$788.00K-13.4%
Q3 FY2021Sep 30, 2021$712.00K+6.9%
Q2 FY2021Jun 30, 2021$464.00K+11.0%
Q1 FY2021Mar 31, 2021$571.00K+30.1%
Q4 FY2020Dec 31, 2020$910.00K+69.5%
Q3 FY2020Sep 30, 2020$666.00K+24.7%
Q2 FY2020Jun 30, 2020$418.00K-1.9%
Q1 FY2020Mar 31, 2020$439.00K+20.6%
Q4 FY2019Dec 31, 2019$537.00K+8.0%
Q3 FY2019Sep 30, 2019$534.00K+92.8%
Q2 FY2019Jun 30, 2019$426.00K+30.3%
Q1 FY2019Mar 31, 2019$364.00K0.0%
Q4 FY2018Dec 31, 2018$497.00K+151.1%
Q3 FY2018Sep 30, 2018$277.00K+61.0%
Q2 FY2018Jun 30, 2018$327.00K+227.1%
Q1 FY2018Mar 31, 2018$364.00K+691.0%
Q4 FY2017Dec 31, 2017$197.96K+200.6%
Q3 FY2017Sep 30, 2017$172.05K+6.0%
Q2 FY2017Jun 30, 2017$99.98K–
Q1 FY2017Mar 31, 2017$46.02K–
Q4 FY2016Dec 31, 2016$65.86K–
Q3 FY2016Sep 30, 2016$162.32K–

More BioLargo figures

See a number that looks wrong?